‘Making it Meaningful’: Co-designing an intervention to improve medication safety for people from culturally and linguistically diverse backgrounds accessing cancer services.

This study reports on the process of using an adapted Experienced-Based Co-Design (EBCD) conducted with culturally and linguistically diverse (CALD) consumers and cancer service staff to co-design the novel ‘Making it Meaningful’(MiM) instrument at a cancer service in Australia. Multi-source experiential and contextual information was gathered in phase 1 of the co-design and this evidence, coupled with knowledge gathered via a feedback event was used to inform three co-design workshops in phase 2. A series of meetings were conducted prior to and in between the workshops. Theory was progressively integrated into the workshop content. Two Mandarin speaking CALD consumers and three cancer service staff participated as co-design members. Workshops were supported by a multilingual fieldworker, co-facilitated by researchers and a consumer co-facilitator, and conducted using a hybrid model (face-to-face or online participation). In the first workshop members democratically selected to focus on a strategy to enable CALD consumers to make non-emergency urgent contact with the cancer service for medication related communication. The second workshop resulted in consensus to develop an accessible instrument that would identify appropriate contacts and information sources for medication management between appointments. In the third workshop, the prototype MiM instrument was developed and refined. The MiM is a novel instrument designed with CALD consumers to enhance their knowledge of medication management and empower them to contact cancer service staff about medication safety concerns. Feasibility testing is the next step with successful implementation requiring senior health leadership support and involvement of co-design members as change agents.
Related content
-
Quality & Clinical Excellence
Accompanying People Affected by Cancer in Their Return to Life After Treatment: A Report on an Experiment Conducted in Canada
This study aims to assess family doctors’ perceived needs for improved patient follow-up post-acute treatment in oncology departments, specifically focusing on the Patient Oriented Discharge Summary (PODS) for individuals living with cancer.
Learn more -
Culture & Leadership | Patient Family & Community Engagement | Quality & Clinical Excellence | Staff & Provider Engagement
PX Chat – Leading with Equity: DEI & the Patient Experience in Today’s Climate
12pm ET / 11am CT / 10am MT / 9am PT – In a time of heightened political and cultural tension, advancing diversity, equity, and inclusion (DEI) in healthcare is both more critical and more complex than ever. This PX Chat offers a dedicated space for members of The Beryl Institute focused on DEI efforts
Learn more -
Environment & Hospitality | Quality & Clinical Excellence
Applying Equity, Diversity, and Inclusion in Co-Design with Patient Experience Partners
If diversity of your PFACs is a top strategic priority for your hospital, then this learning bite is for you. North York General Hospital shares how it built a recruitment campaign around three actions that led to hiring 14 new advisors from underrepresented communities. With enhanced diversity in their PFACs, the hospital can now better
Learn more